Meeting
Abstract Number: 41
SHM Converge 2023
Background: Alcohol use disorder (AUD) is the most prevalent substance use disorder, but most patients with AUD do not receive evidence-based medications for AUD (MAUD), including naltrexone or acamprosate. Inpatient addiction consult services (ACS) may offer an opportunity to start medical treatment for hospitalized patients with AUD, but it is unknown if ACS are associated […]
Abstract Number: 60
SHM Converge 2023
Background: Unlike other chronic conditions such as diabetes mellitus and heart disease, substance use disorder (SUD) has only recently been recognized by the medical community recently as a medical condition, and stigmatizing beliefs have lingered. Formal teaching about SUD has been shown to foster a more positive attitude towards these patients among medical trainees. Attitudes […]
Abstract Number: 131
SHM Converge 2023
Background: Management of heart failure (HF) patients revolves around optimization of guideline directed medical therapy (GDMT) and routine monitoring. Substance use plays a major role as the etiology of HF, especially in a low socioeconomic area with ethnic and racial minority patients. The aim of this study is to find the correlation of alcohol, tobacco […]
Abstract Number: 193
SHM Converge 2023
Background: Adolescent e-cigarette use was declared as an epidemic by the U.S. Surgeon general in 2018 and has severe health consequences, including e-cigarette, or vaping, product use-associated lung injury (EVALI). It is known that e-cigarette use is associated with mental health disorders and psychosocial stressors; however, there is a knowledge gap in characterizing psychosocial stressors […]